[1P-296] Insulinotropic activity of sialidase inhibitor with a glucose-dependent manner

^○Yuka Fujita¹, Akira Minami¹, Yukiko Kaneko¹, Toshiaki Sawatani¹, Tadamune Otsubo², Kiyoshi Ikeda², Yuki Kurebayashi¹, Tadanobu Takahashi¹, Taeko Miyagi³, Tomohisa Ishikawa¹, Takashi Suzuki¹ (1.Sch. of Pharmaceu. Sci., Univ, of Shizuoka, 2.Sch. of Pharmaceu. Sci., Hiroshima Int Univ., 3.Miyagi Cancer Center Research Institute, Natori, Japan)

キーテクノロジー：低血糖副作用回避型糖尿病治療薬

糖尿病、シアリダーゼ、低血糖、Neu3、インスリン分泌